Infusion Pumps and Devices: Technologies and Global Markets

Report Code: HLC071E

Publish Date: Sep 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Report Includes

  • 54 data tables and 56 additional tables
  • An analysis of the global markets for infusion pumps and devices
  • Analyses of global market trends, with market revenue data from 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Estimate of the current market size, revenue prospects, and a market share analysis by product type, therapeutic application, end user and region
  • Facts and figures pertaining to the market dynamics, technological trends and advances, regulations, and the influence of macroeconomic factors
  • Insights into the rapid changes in product offerings following a series of high-profile product recalls
  • A look at recently granted patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
  • Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
  • Company profiles of market leaders, including Baxter, BD, Insulet Corp., Medtronic, and B. Braun. SE

Report Scope

The current report provides detailed information about the infusion pump market, including market projections for 2029 and market shares for key market players. It details the market size of infusion pumps based on products, applications and end users. Based on product, infusion pumps are categorized into general purpose (large-volume, syringe, electronic ambulatory and elastomeric) and specialty types (insulin, patient-controlled analgesia (PCA), enteral, and implantable infusion pumps). The report excludes consumables, accessories, and software systems used for infusion. Based on application, the report is segmented into diabetes management, pain management/analgesia, nutrition, chemotherapy/oncology and other applications. Based on end user, the market is categorized into hospitals, home care and alternate site care settings.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $9.5 billion
Market size forecast $14.7 billion
Growth rate CAGR of 7.7% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Products, Applications, End Users and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, U.K., France, Italy, China, Japan, and India
Key Market Drivers
  • Growing chronic disease coupled with rising geriatric population.
  • Rising number of surgeries.
  • Increasing demand for ambulatory infusion pumps, mainly in home care settings.
Companies studied
AVANOS MEDICAL INC.B. BRAUN SE
BAXTERBD
CARDINAL HEALTHFRESENIUS SE & CO. KGAA
ICU MEDICAL INC.INSULET CORP.
MEDTRONICSHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
TERUMO CORP.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global infusion pump market is expected to grow at a compound annual growth rate (CAGR) of 7.7% to reach $ 14.7 billion by 2029 from $10.1 billion in 2024.
Key drivers of the infusion pump market are the growing chronic disease coupled with the rising geriatric population, rising number of surgeries, and increasing demand for ambulatory infusion pumps, mainly in home care settings.
The infusion pump market is segmented based on product, application, end user, and region.
The specialty infusion pumps segment will dominate the market by the end of 2029.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Infusion Pumps and Devices: Technologies and Global Markets141Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview11Free
Chapter- 3: Market Dynamics10Free
Chapter- 4: Emerging Technologies and Developments10Free
Chapter- 5: Market Segmentation Analysis50Free
Chapter- 6: Competitive Intelligence6Free
Chapter- 7: Sustainability in Infusion Pumps and Devices: An ESG Perspective5Free
Chapter- 8: Appendix46Free
Published - Aug-2022| Analyst - BCC Publishing| Code - HLC071D

Report Highlights

The global market for infusion pumps was valued at $9.8 billion in 2021 and is estimated to grow from $10.3 billion in 2022 to $15.0 billion in 2027 with compound annual growth rate (CAGR) of 7.7% for the period of 2022-2027.

Report Includes

  • 34 data tables and 69 additional tables.
  • An overview of the global market and technologies for infusion pumps and devices
  • Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market and evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
  • Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players, including Intera Oncology, ICU Medical Inc, Cardinal Health and ZYNO Solution LLC

     

Published - Nov-2016| Analyst - Shalini Shahani Dewan| Code - HLC071C

Report Highlights

The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.

Report Includes

  • An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics.
  • Analyses of global market trends with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market.
  • Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product.
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls.
  • Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment.
  • Profiles of major players in the industry.

Published - Sep-2013| Analyst - Shalini Shahani Dewan| Code - HLC071B

Report Highlights

The global revenue for the infusion pumps and devices market reached $17.8 billion in 2012. This market is expected to grow to $18.7 billion in 2013 and then to $23.7 billion by 2018 at a compound annual growth (CAGR) of 4.8% from 2013-2018.

Report Includes

  • An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market
  • Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
  • Examination of the transition to “smart pump” technology and the complex systems that complement and compete with infusion pumps as modes of treatment
  • Comprehensive company profiles of major players in the industry.

Published - Feb-2010| Analyst - Thomas Fuller| Code - HLC071A

Report Highlights

  • Global spending on infusion pumps were $6.4 billion in 2008 which increased to $7 billion in 2009. This is projected to reach $9.6 billion in 2014 at a compound annual growth rate (CAGR) of 6.5%
  • Spending alone in USA was nearly $3.3 billion in 2008 which increased to $3.6 billion in 2009. This is projected to reach $4.8 billion in 2014 at a compound annual growth rate (CAGR) of 5.8%
  • Spending in Europe was $1.9 billion in 2008, which increased slightly in 2009 to $2 billion. This market is projected to reach approx $2.8 billion in 2014, for a 5-year CAGR of 6.4%.

Related Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Patient Monitoring Devices: Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - HLC038G

The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Infusion Pumps and Devices: Technologies and Global Markets
Sample Report